What packaging formats are available for this infusion?

Available in glass infusion bottles, polypropylene infusion bottles, vertical polypropylene infusion bags, and multi-layer co-extruded film infusion bags, all containing 500ml.

Who is the manufacturer of this product?

The product is manufactured by Shijiazhuang No.4 Pharmaceutical Co., Ltd., a leading enterprise in the Chinese pharmaceutical industry with 70 years of history.

What are the terms of payment and lead time for export?

Terms of payment include LC and T/T. The average lead time is one month during peak season.

Ringer Lactate Injection

Name: Ringer Lactate Injection
Brand: Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
SKU: 1951787291

Hebei, ChinaShijiazhuang No. 4 Pharmaceutical Co., Ltd.

US$0.17

100,000 Bottle

Product profile

Customization

Available

Application

Intravenous Injection

Usage Mode

Intravenous Injection

Model NO.

250ml 500ml

Suitable for

Elderly, Children, Adult

State

Liquid

Shape

Solution

Type

Intravenous Injection

Pharmaceutical Technology

Chemical Synthesis

Transport Package

Carton

Specification

250ml 500ml

Trademark

SHIMEN

Origin

China

HS Code

3004909099

Production Capacity

1000000000/Year

Key features

Comprehensive Electrolyte Balance: Adjusts humor electrolyte equilibrium and corrects metabolic acid toxicosis or dehydration.

Precise Composition Formula: Each 500ml contains Sodium Lactate 1.55g, Sodium chloride 3.00g, Potassium chloride 0.15g, and Calcium chloride 0.10g.

Clear Liquid Formulation: Colorless clear liquid with osmolality of 240~270mOsmol/kg for safe intravenous administration.

Flexible Packaging Options: Available in glass bottles, polypropylene bottles, and various multi-layer co-extruded film bags.

Long Shelf Life Stability: Sealed storage ensures a stable expiry date of 36 months for reliable supply.

GMP Certified Manufacturing: Produced by Shijiazhuang No.4 Pharmaceutical Co., Ltd. with full automation and international advanced technology.

Global Export Capability: Exported to over 80 countries across Asia, Americas, Europe, Oceania, and Africa.

70-Year Industry Experience: Leading manufacturer with a 70-year business history in R&D, manufacture, and sales of intravenous infusions.

Company profile

Shijiazhuang No. 4 Pharmaceutical Co., Ltd.

Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2002-01-01Nearest Port: Tianjin Xingang, Qingdao, ShanghaiAverage Response Time: ≤11.79hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, EXW

AI-Powered supplier vetting

SummaryShijiazhuang No. 4 Pharmaceutical Co., Ltd. is identified as a Chinese public pharmaceutical manufacturer based in Hebei, with products spanning infusion solutions, injections, tablets, capsules, inhalation products, and other medical materials. The supplier reports ISO 9001, ISO 14001, and GMP certifications, more than ten production lines, automated and information-based production and logistics processes, and substantial stated output across several dosage forms. Its export activity began in 2002, although exports represent only 1%–10% of total sales. The company describes integrated R&D, manufacturing, and marketing capabilities, but the provided information does not establish specific after-sales programs, customization services, or named customer cases. Financial strength cannot be assessed because financial data is excluded.

Supplier typeThe supplier is explicitly classified as a Manufacturer/Factory and is described as an integrated pharmaceutical enterprise covering R&D, industrial production, and marketing. Its listed business covers health and medicine products, including injections, infusion solutions, tablets, capsules, and related dosage forms.

CertificationsThe supplier reports ISO 9001, ISO 14001, and GMP certifications. It also states that production is organized strictly according to GMP requirements, providing explicit evidence of formal quality, environmental, and pharmaceutical manufacturing systems.

R&D capabilityThe supplier describes an integrated R&D, production, and marketing model, reports 50 R&D engineers, and states that its production lines integrate leading equipment and technology at an international advanced level. This supports established technical and development capability, although no specific patents, new-product results, or R&D investment details are provided.

Production capacityProduction capability is strongly supported by more than ten production lines, automated and information-based production and logistics processes, and stated annual outputs of 1.5 billion large-volume injection units and 1 billion units each for tablets, capsules, and small-volume injections. The company also reports more than ten international advanced infusion-solution lines and exports through both agency and self-operated channels.

Product Q&A

Q:What are the main ingredients in Ringer Lactate Injection?

Each 500ml contains Sodium Lactate 1.55g, Sodium chloride 3.00g, Potassium chloride 0.15g, and Calcium chloride 0.10g, with Water for injection as the excipient.

Q:What is the primary indication for using this product?

It is indicated to adjust the equilibrium of humor electrolyte acid and alkali, and is used for metabolic acid toxicosis or dehydration caused by metabolic acid toxicosis.

Q:What is the recommended dosage and administration speed?

The general dose for adults is 500-1000ml/time, administered by phleboclysis at a speed of 300~500ml/hour, adjusted according to body weight and age.

Q:What are the main contraindications for this injection?

It is forbidden for patients with heart failure, acute pulmonary edema, cerebral edema, obvious lactic acidosis, severe hepatic inadequacy, or serious renal failure with oliguria or anuria.

Q:How should the product be stored and what is its shelf life?

The product requires sealed storage and has an expiry date of 36 months.